Ledger.Open graph →
SEC Form D · filed April 29, 2022

Kelonia Therapeutics, Inc

Offering
$50.3M
Sold
$50.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Bryan Roberts · Hampton, NJDirectorMichael Birnbaum · Cambridge, MADirectorKevin Friedman · Cambridge, MAExec · DirectorBryan Roberts · Fort Washington, PADirectorKevin Friedman · Cambridge, MAExec · DirectorMichael Fischbach · Cambridge, MADirectorBob More · CAMBRIDGE, MADirectorMichael Fischbach · Cambridge, MADirectorMichael Birnbaum · Cambridge, MADirectorBob More · San Mateo, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗